Satellos Bioscience MSLE
NASDAQ MSLE
$6.70 -0.30 (-4.29%)
At close: Oct 21, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Other Non-Current Liabilities (2024 - 2026)

Updated

Analysis

Satellos Bioscience (MSLE) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Satellos Bioscience 98.81 Mn -109.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.33 Mn
Mar 31, 2026 19.33 Mn
Dec 31, 2025 15.48 Mn
Dec 31, 2024 19.25 Mn
API Access

Satellos Bioscience Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MSLE&period=max&api_key=YOUR_API_KEY